U.S. drugmaker earnings heat up this week with spotlight on vaccine news

📆 28/07/2020 02:47:00
📰 Reuters

⏱ Reading Time:
19 sec. here
2 min. at publisher
📊 Quality Score:
News: 11%
Publisher: 97%

France Nouvelles Nouvelles

France Dernières Nouvelles,France Actualités

Several major U.S. drugmakers will report second-quarter results this week, with investors eager for fresh details from Pfizer Inc , Merck & Co and others on their efforts to develop vaccines and therapies against the novel coronavirus.

Globally, drugmakers are expected to increase second-quarter earnings per share by 2%, after they rose 17% in the first quarter, according to Cowen & Co.

Pfizer, which has released early data on its vaccine candidate being developed with German biotech BioNTech SE , will kick off the week of drugmaker earnings on Tuesday morning. Gilead’s antiviral treatment, remdesivir, has become a key weapon for many countries after the intravenously administered medicine helped shorten hospital recovery times in a U.S. trial.

Écrire un Commentaire

Well, I never expected that ! 🤑

Hey Democrats! Here, money to redistribute! *crickets*

Don’t need it, Doc on steps has a cure.

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

US stocks rise as tech trades higher, investors await stimulus bill | Markets InsiderUS stocks rose on Monday as investors looked to major earnings on deck this week and awaited the release of the GOP's coronavirus stimulus plan.... Meanwhile, their customers are getting screwed.
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »